BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22443680)

  • 1. Daming capsule restores endothelial dysfunction induced by high-fat diet.
    Zhang R; Niu H; Wang N; Sun L; Xu Y; Zhao R; Ban X; Yu Y; Yang B; Ai J
    BMC Complement Altern Med; 2012 Mar; 12():21. PubMed ID: 22443680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasorelaxant effects of Cerebralcare Granule® are mediated by NO/cGMP pathway, potassium channel opening and calcium channel blockade in isolated rat thoracic aorta.
    Qu Z; Zhang J; Gao W; Chen H; Guo H; Wang T; Li H; Liu C
    J Ethnopharmacol; 2014 Aug; 155(1):572-9. PubMed ID: 24924524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.
    Chakkarwar VA
    Vascul Pharmacol; 2011; 55(5-6):163-8. PubMed ID: 21864717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
    Nirwane A; Pawar V; Majumdar A
    J Complement Integr Med; 2015 Jun; 12(2):143-51. PubMed ID: 25870973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
    Shah DI; Singh M
    Vascul Pharmacol; 2006 Mar; 44(3):177-82. PubMed ID: 16442349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
    Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vascular endothelium masks the persistent inhibition of rat thoracic arterial tone induced by S-nitrosoglutathione.
    Sarr M; Sar FB; Gueye L; Kane MO; Wele A; Diallo AS; Schini-Kerth V; Muller B
    Cardiovasc J Afr; 2011; 22(1):7-13. PubMed ID: 21298199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury.
    Bi XY; He X; Zhao M; Yu XJ; Zang WJ
    J Cardiovasc Pharmacol; 2013 May; 61(5):391-400. PubMed ID: 23364605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits.
    Maeso R; Aragoncillo P; Navarro-Cid J; Ruilope LM; Diaz C; Hernández G; Lahera V; Cachofeiro V
    Gen Pharmacol; 2000 Apr; 34(4):263-72. PubMed ID: 11282220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxing effects of phytoestrogen alpha-zearalanol on rat thoracic aorta rings in vitro.
    Wang W; Jiang D; Zhu Y; Liu W; Duan J; Dai S
    Chin J Physiol; 2009 Apr; 52(2):99-105. PubMed ID: 19764345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms.
    Castro MM; Rizzi E; Rascado RR; Nagassaki S; Bendhack LM; Tanus-Santos JE
    Eur J Pharmacol; 2004 Sep; 498(1-3):189-94. PubMed ID: 15363994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in rat adjuvant-induced arthritis: up-regulation of the vascular arginase pathway.
    Prati C; Berthelot A; Wendling D; Demougeot C
    Arthritis Rheum; 2011 Aug; 63(8):2309-17. PubMed ID: 21484767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise training activates large-conductance calcium-activated K(+) channels and enhances nitric oxide production in rat mesenteric artery and thoracic aorta.
    Chen SJ; Wu CC; Yen MH
    J Biomed Sci; 2001; 8(3):248-55. PubMed ID: 11385296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
    De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
    Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of nitric oxide and hydrogen sulfide in the anti-atherosclerotic effect of atorvastatin.
    Liu X; Ma D; Zheng S; Zha K; Feng J; Cai Y; Jiang F; Li J; Fan Z
    J Cardiovasc Med (Hagerstown); 2015 Jan; 16(1):22-8. PubMed ID: 24933195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
    Gong X; Ma Y; Ruan Y; Fu G; Wu S
    Exp Gerontol; 2014 Apr; 52():9-17. PubMed ID: 24463049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity.
    Li R; Wang WQ; Zhang H; Yang X; Fan Q; Christopher TA; Lopez BL; Tao L; Goldstein BJ; Gao F; Ma XL
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1703-8. PubMed ID: 17895290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.